These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37709527)

  • 1. Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying index-based and patient-based definitions of remission: a cross-sectional study.
    Leung YY; Eder L; Orbai AM; Coates LC; de Wit M; Smolen JS; Kiltz U; Palominos P; Canete JD; Scrivo R; Balanescu A; Dernis E; Meisalu S; Soubrier M; Kalyoncu U; Gossec L
    RMD Open; 2023 Sep; 9(3):. PubMed ID: 37709527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries.
    Gorlier C; Orbai AM; Puyraimond-Zemmour D; Coates LC; Kiltz U; Leung YY; Palominos P; Cañete JD; Scrivo R; Balanescu A; Dernis E; Tälli S; Ruyssen-Witrand A; Soubrier M; Aydin SZ; Eder L; Gaydukova I; Lubrano E; Kalyoncu U; Richette P; Husni ME; de Wit M; Smolen JS; Gossec L
    Ann Rheum Dis; 2019 Feb; 78(2):201-208. PubMed ID: 30442648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study.
    Coates LC; Nash P; Kvien TK; Gossec L; Mease PJ; Rasouliyan L; Pricop L; Jugl SM; Gandhi KK; Gaillez C; Smolen JS
    Semin Arthritis Rheum; 2020 Aug; 50(4):709-718. PubMed ID: 32521325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies.
    Schneeberger EE; Citera G; Nash P; Smolen JS; Mease PJ; Soriano ER; Helling C; Szumski AE; Mundayat R; de León DP
    Semin Arthritis Rheum; 2023 Feb; 58():152134. PubMed ID: 36476498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Different Remission and Low Disease Definitions in Psoriatic Arthritis and Evaluation of Their Prognostic Value.
    Coates LC; Gottlieb AB; Merola JF; Boone C; Szumski A; Chhabra A
    J Rheumatol; 2019 Feb; 46(2):160-165. PubMed ID: 30323006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort.
    van Mens LJJ; van de Sande MGH; van Kuijk AWR; Baeten D; Coates LC
    Ann Rheum Dis; 2018 Feb; 77(2):251-257. PubMed ID: 29080861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required?
    Kilic G; Kilic E; Nas K; Kamanlı A; Tekeoglu İ
    Rheumatol Int; 2019 Jan; 39(1):73-81. PubMed ID: 30426235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission and low disease activity in psoriatic arthritis publications: a systematic literature review with meta-analysis.
    Hagège B; Tan E; Gayraud M; Fautrel B; Gossec L; Mitrovic S
    Rheumatology (Oxford); 2020 Aug; 59(8):1818-1825. PubMed ID: 32118267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis.
    Wervers K; Vis M; Tchetveriko I; Gerards AH; Kok MR; Appels CWY; van der Graaff WL; van Groenendael JHLM; Korswagen LA; Veris-van Dieren JJ; Hazes JMW; Luime JJ
    Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1764-1770. PubMed ID: 29609220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen Countries.
    Orbai AM; Perin J; Gorlier C; Coates LC; Kiltz U; Leung YY; Palominos PE; Cañete JD; Scrivo R; Balanescu A; Dernis E; Tälli S; Ruyssen-Witrand A; Soubrier M; Aydin S; Eder L; Gaydukova I; Lubrano E; Kalyoncu U; Richette P; Husni ME; Smolen JS; de Wit M; Gossec L
    Arthritis Care Res (Hoboken); 2020 Dec; 72(12):1772-1779. PubMed ID: 31609525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual Disease Activity and Associated Factors in Psoriatic Arthritis.
    Lubrano E; Scriffignano S; Perrotta FM
    J Rheumatol; 2020 Oct; 47(10):1490-1495. PubMed ID: 31676704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Composite Indices Tailored for Psoriatic Arthritis Treated with csDMARD and bDMARD: A Cross-sectional Analysis of a Longitudinal Cohort.
    Lubrano E; De Socio A; Perrotta FM
    J Rheumatol; 2017 Aug; 44(8):1159-1164. PubMed ID: 28572467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What influences patients' opinion of remission and low disease activity in psoriatic arthritis? Principal component analysis of an international study.
    Coates LC; Robinson DE; Orbai AM; Kiltz U; Leung YY; Palominos P; Cañete JD; Scrivo R; Balanescu A; Dernis E; Meisalu S; Ruyssen-Witrand A; Eder L; de Wit M; Smolen JS; Lubrano E; Gossec L
    Rheumatology (Oxford); 2021 Nov; 60(11):5292-5299. PubMed ID: 33751029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices.
    Lubrano E; Scriffignano S; Azuaga AB; Ramirez J; Cañete JD; Perrotta FM
    RMD Open; 2020 Mar; 6(1):. PubMed ID: 32179713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis.
    Queiro R; Cañete JD; Montilla C; Abad MA; Montoro M; Gómez S; Cábez A;
    J Rheumatol; 2019 Jul; 46(7):710-715. PubMed ID: 30709957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inconsistencies of the Disease Activity Assessment Tools for Psoriatic Arthritis: Challenges to Rheumatologists.
    Gezer HH; Duruöz MT; Nas K; Kılıç E; Sargın B; Kasman SA; Alkan H; Şahin N; Cengiz G; Cüzdan N; Gezer İA; Keskin D; Mülkoğlu C; Reşorlu H; Sunar İ; Bal A; Küçükakkaş O; Yurdakul OV; Melikoğlu MA; Baykul M; Ayhan FF; Bodur H; Çalış M; Çapkın E; Devrimsel G; Gök K; Hizmetli S; Kamanlı A; Keskin Y; Ecesoy H; Kutluk Ö; Şen N; Şendur ÖF; Tekeoğlu İ; Tolu S; Toprak M; Tuncer T
    Joint Bone Spine; 2022 May; 89(3):105296. PubMed ID: 34656752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of obesity on quality of life, psychological status, and disease activity in psoriatic arthritis: a multi‑center study.
    Gok K; Nas K; Tekeoglu I; Sunar I; Keskin Y; Kilic E; Sargin B; Acer Kasman S; Alkan H; Sahin N; Cengiz G; Cuzdan N; Albayrak Gezer İ; Keskin D; Mulkoglu C; Resorlu H; Bal A; Duruoz MT; Kucukakkas O; Yurdakul OV; Alkan Melikoglu M; Aydin Y; Ayhan FF; Bodur H; Calis M; Capkin E; Devrimsel G; Ecesoy H; Hizmetli S; Kamanli A; Kutluk O; Sen N; Sendur OF; Tolu S; Toprak M; Tuncer T
    Rheumatol Int; 2022 Apr; 42(4):659-668. PubMed ID: 34453579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal disease activity and remission in patients with psoriatic arthritis with elevated body mass index: an observational cohort study in the Swiss Clinical Quality Management cohort.
    Vallejo-Yagüe E; Burkard T; Micheroli R; Burden AM
    BMJ Open; 2022 Sep; 12(9):e061474. PubMed ID: 36115672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring disease activity in psoriatic arthritis: PASDAS implementation in a tightly monitored cohort reveals residual disease burden.
    Mulder MLM; van Hal TW; van den Hoogen FHJ; de Jong EMGJ; Vriezekolk JE; Wenink MH
    Rheumatology (Oxford); 2021 Jul; 60(7):3165-3175. PubMed ID: 33331947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Composite Measure Remission Targets in Psoriatic Arthritis.
    Farkas F; Ikumi N; Elmamoun M; Szentpetery A; FitzGerald O
    J Rheumatol; 2021 Aug; 48(8):1272-1278. PubMed ID: 33722944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.